大发快三网络彩票

      <b id="flgyrntoi" ><center id="flgyrntoi" ></center></b>

    1. <code id="flgyrntoi" ><font id="flgyrntoi" ></font></code>
      <noframes id="flgyrntoi" ></noframes><small id="flgyrntoi" ><input id="flgyrntoi" ></input></small>
      <label id="flgyrntoi" ></label><th id="flgyrntoi" ><output id="flgyrntoi" ></output></th>

      <object id="flgyrntoi" ><delect id="flgyrntoi" ></delect></object>
    2. YaoPharma’s new API Tenofovir Disoproxil Fumarate received CFDA approval

      22 / 02 / 2017

      On Feb. 21, 2017, YaoPharma received the registration certificate of “Tenofovir Disoproxil Fumarate” from CFDA.

      Tenofovir Disoproxil Fumarate is a phosphodiester analogue of the aliphatic nucleoside adenosine monophosphate, which inhibits the activity of the human immunodeficiency virus -1 (HIV-1) reverse transcriptase and hepatitis B virus DNA polymerase.

      YaoPharma developed this product with a new synthetic route, successfully realized the localization of the drug, providing an important guarantee for the accessibility and affordability of patients.

        <b id="flgyrntoi" ><center id="flgyrntoi" ></center></b>

      1. <code id="flgyrntoi" ><font id="flgyrntoi" ></font></code>
        <noframes id="flgyrntoi" ></noframes><small id="flgyrntoi" ><input id="flgyrntoi" ></input></small>
        <label id="flgyrntoi" ></label><th id="flgyrntoi" ><output id="flgyrntoi" ></output></th>

        <object id="flgyrntoi" ><delect id="flgyrntoi" ></delect></object>